UNCY - Unicycive Therapeutics Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Capital Market Current Price & Safety Score Price: 3.58 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -0.37 StockBond Score: -4.08 Company Description Unicycive Therapeutics Inc is a USbased biotechnology company dedicated to the creation of innovative treatments for kidney diseases Its development pipeline includes Renazorb a therapy for hyperphosphatemia in chronic kidney disease patients and UNI 494 which is being developed to treat acute kidney injury Founded in 2016 the firm is headquartered in Los Altos California